Use of Aloe Vera for Radiotherapy-Related Skin Reactions
Should aloe vera be used on the skin to prevent radiodermatitis?
Side-Effect Management
Adherence to Topical Management of Hand-Foot Skin Reaction Poor Among Patients Treated With Regorafenib
Researchers sought to measure adherence to topical management regimens among patients with HFSR due to treatment with regorafenib.
Patient Reports Indicate Discussions on Symptom Management Are Insufficient
Researchers surveyed patients on pain, fatigue, and distress due to their diagnosis, as well as their perception of management of these symptoms.
Dermatology Life Quality Index Valid for Assessing Radiodermatitis in Breast Cancer Patients
A pilot study revealed the effectiveness of the DLQI in assessing quality of life measures in women with breast cancer treatment-related radiodermatitis.
Meditation Made Easy: Simple Practices for Patients With Cancer and Their Caregivers
This description of meditation practice, with some simple exercises, can serve as an introduction to its benefits or just help cancer patients and caregivers better cope with disease-related stress.
Preparing Nurses for Possible Adverse Events with CAR-T Therapy
A multidisciplinary program developed to educate nurses on recognizing and managing the signs and symptoms of CAR-T cell therapy adverse effects.
Cancer Radiotherapy Poses Long-Term Risks for Children’s Spinal Development
A report from a European working group of pediatric radiation oncologists focuses on recommendations for safer delivery of radiotherapy to children, especially in dose distributions involving spinal vertebrae.
Prophylaxis Improves Postchemotherapy Nausea/Vomiting Frequency, Hospitalizations
Postchemotherapy hospitalizations and costs are higher for patients receiving highly emetogenic chemotherapy with no prophylaxis treatment.
G-CSF Support Increases Overall Survival, But Risk of Secondary Malignancies Also Higher
A meta-analysis of 14 randomized, controlled trials was conducted to determine if combining G-CSF with intensified chemotherapy improved overall survival.
Clinical Characteristics That Increase Risk of Chemotherapy-Induced Febrile Neutropenia Identified
Researchers analyzed data from more than 15,000 patients in Southern California with various cancers to identify clinical factors that contribute to the risk of developing chemotherapy-induced febrile neutropenia.
Next post in Side-Effect Management
